About: Aclidinium bromide/formoterol

An Entity of Type: combination drug, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Aclidinium bromide/formoterol, sold under the brand names Duaklir and Brimica, is a fixed-dose combination medication for inhalation, used in the management of chronic obstructive pulmonary disease (COPD). It consists of aclidinium bromide, a long-acting muscarinic antagonist, and formoterol, a long-acting β2 agonist.

Property	Value
dbo:abstract	Aclidinium bromide/formoterol, sold under the brand names Duaklir and Brimica, is a fixed-dose combination medication for inhalation, used in the management of chronic obstructive pulmonary disease (COPD). It consists of aclidinium bromide, a long-acting muscarinic antagonist, and formoterol, a long-acting β2 agonist. (en)
dbo:alternativeName	Brimica Genuair, Duaklir Genuair, Duaklir Pressair (en)
dbo:casNumber	2446159-07-3
dbo:kegg	D11857
dbo:wikiPageExternalLink	https://druginfo.nlm.nih.gov/drugportal/name/aclidinium%20bromide https://druginfo.nlm.nih.gov/drugportal/rn/43229-80-7
dbo:wikiPageID	46862155 (xsd:integer)
dbo:wikiPageLength	4003 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1073120247 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Inhalation dbr:Chronic_obstructive_pulmonary_disease dbr:Muscarinic_antagonist dbr:Long-acting_beta-adrenoceptor_agonist dbr:Aclidinium_bromide dbc:Muscarinic_antagonists dbr:Formoterol dbc:AstraZeneca_brands dbc:Combination_drugs dbc:Beta-adrenergic_agonists dbc:Bronchodilators dbr:Fixed-dose_combination
dbp:atcPrefix	R03 (en)
dbp:atcSuffix	AL05 (en)
dbp:casNumber	2446159 (xsd:integer)
dbp:class	dbr:Long-acting_beta-adrenoceptor_agonist Long-acting muscarinic antagonist (en)
dbp:component	Aclidinium bromide (en) Formoterol (en)
dbp:dailymedid	Duaklir (en)
dbp:kegg	D11857 (en)
dbp:legalAu	S4 (en)
dbp:legalEu	Rx-only (en)
dbp:legalStatus	Rx-only (en)
dbp:legalUk	POM (en)
dbp:legalUs	Rx-only (en)
dbp:pregnancyAu	B3 (en)
dbp:pregnancyUs	N (en)
dbp:routesOfAdministration	Inhalation (en)
dbp:tradename	Brimica Genuair, Duaklir Genuair, Duaklir Pressair (en)
dbp:type	combo (en)
dbp:wikiPageUsesTemplate	dbt:Respiratory-system-drug-stub dbt:Adrenergic_receptor_modulators dbt:Cite_web dbt:Infobox_drug dbt:Portal_bar dbt:Reflist dbt:Short_description dbt:Drugs.com dbt:Muscarinic_acetylcholine_receptor_modulators dbt:Drugs_for_obstructive_airway_diseases
dcterms:subject	dbc:Muscarinic_antagonists dbc:AstraZeneca_brands dbc:Combination_drugs dbc:Beta-adrenergic_agonists dbc:Bronchodilators
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:CombinationDrug dbo:Drug
rdfs:comment	Aclidinium bromide/formoterol, sold under the brand names Duaklir and Brimica, is a fixed-dose combination medication for inhalation, used in the management of chronic obstructive pulmonary disease (COPD). It consists of aclidinium bromide, a long-acting muscarinic antagonist, and formoterol, a long-acting β2 agonist. (en)
rdfs:label	Aclidinium bromide/formoterol (en)
owl:sameAs	wikidata:Aclidinium bromide/formoterol dbpedia-fa:Aclidinium bromide/formoterol dbpedia-vi:Aclidinium bromide/formoterol https://global.dbpedia.org/id/2MrLP
prov:wasDerivedFrom	wikipedia-en:Aclidinium_bromide/formoterol?oldid=1073120247&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:Aclidinium_bromide/formoterol
is dbo:wikiPageRedirects of	dbr:Aclidinium/formoterol dbr:Aclidinium_bromide/formoterol_fumarate dbr:Aclidinium_bromide/formoterol_fumarate_dihydrate dbr:Duaklir dbr:Duaklir_Genuair dbr:Duaklir_Pressair dbr:Brimica dbr:Formoterol/aclidinium
is dbo:wikiPageWikiLink of	dbr:Aclidinium/formoterol dbr:Aclidinium_bromide dbr:Formoterol dbr:Aclidinium_bromide/formoterol_fumarate dbr:Aclidinium_bromide/formoterol_fumarate_dihydrate dbr:ATC_code_R03 dbr:Duaklir dbr:Duaklir_Genuair dbr:Duaklir_Pressair dbr:Brimica dbr:Formoterol/aclidinium
is foaf:primaryTopic of	wikipedia-en:Aclidinium_bromide/formoterol